Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.




FirmAnalyst Phone/Email
BofA Securities
Derik de Bruin
Eric Coldwell
Citi Research
Patrick Donnelly
Deutsche Bank Research
George Hill
Evercore ISI
Elizabeth Anderson
David Windley
J.P. Morgan
Tycho Peterson
KeyBanc Capital Markets
Donald Hooker
Morgan Stanley
Tejas Savant
Rachel Elfman
John Sourbeer
Wells Fargo Securities
Dan Leonard
William Blair
John Kreger

Charles River Laboratories International, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Charles River Laboratories International, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Charles River Laboratories International, Inc. or its management. Charles River Laboratories International, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Featured Report

2020 Annual Report (PDF)

Charles River Corporate Citizenship Report
View PDF
Print PDF